Vimarsana
Biggest News Aggregation in the World

Page 36 - Eva Mathews News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eva Mathews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eva Mathews Today - Breaking & Trending Today

Bootmaker Dr Martens sees annual revenue decline after slow winter start - Vimarsana News

Bootmaker Dr Martens sees annual revenue decline after slow winter start

Britain's Dr Martens on Thursday forecast its annual revenue to decline by a high single-digit percentage, after a slow start to the autumn-winter season impacted by warm weather across its three... -November 30, 2023 at 02:27 am EST - MarketScreener

UK's Halfords narrows annual profit forecast range - Vimarsana News

UK's Halfords narrows annual profit forecast range

Bicycles-to-car parts retailer Halfords Group on Wednesday narrowed its annual profit forecast range, lowering the upper end of its expectations due to challenges in the sales in discretionary...

Pets At Home sees life-for-like retail growth ahead of Christmas - Vimarsana News

Pets At Home sees life-for-like retail growth ahead of Christmas

Pets at Home Group said on Tuesday its like-for-like retail growth came in at nearly 4% in the early weeks of the third quarter, as Britons gear up for the Christmas season and continue to spend... -November 28, 2023 at 02:24 am EST - MarketScreener

UK regulator says Adobe's $20 bln Figma deal could harm sector - Vimarsana News

UK regulator says Adobe's $20 bln Figma deal could harm sector

Britain's competition regulator on Tuesday said Photoshop owner Adobe Inc's $20 billion buyout of cloud-based designer platform Figma would likely harm innovation for software used by the vast...

GSK says blood cancer drug meets primary goal in late-stage trial - Vimarsana News

GSK says blood cancer drug meets primary goal in late-stage trial

British drugmaker GSK said on Monday its blood cancer drug Blenrep, when used as a second-line treatment, had met its primary goal of progression free survival in a late-stage trial. In...